Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone
British Journal of Dermatology · 2025
DOI: 10.1093/bjd/ljaf273 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Shosuke Ito und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Hydroquinones, Monophenol Monooxygenase, Ochronosis, Homogentisate 1,2-Dioxygenase. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Policy Research.
Abstract (Originalsprache)
Background
Hydroquinone is widely used for its hypopigmenting effects in treating hyperpigmentation disorders. However, its topical application has been linked to adverse effects, notably exogenous ochronosis, raising concerns about its safety and mechanisms of action.
Objectives
To elucidate the metabolic pathway of hydroquinone in human melanocytes and to clarify the role of tyrosinase in the development of exogenous ochronosis.
Methods
We conducted an in vitro investigation using human tyrosinase to analyse the metabolism of hydroquinone. The study involved assessing the oxidation of hydroquinone in the presence of L-DOPA and L-cysteine, measuring the production of dopaquinone and its subsequent derivatives, including 2-S-cysteinyl–hydroquinone (Cys-HQ) and hydroquinone–pheomelanin (HQ-PM).
Results
Our findings demonstrate that human tyrosinase effectively oxidizes hydroquinone primarily via dopaquinone, with L-cysteine facilitating the formation of Cys-HQ. Further oxidation of Cys-HQ leads to the production of HQ-PM. Notably, the results indicate that tyrosinase activity is crucial for the induction of exogenous ochronosis by hydroquinone. Additionally, while high-molecular-weight hydroquinone derivatives may remain within melanosomes, low-molecular-weight metabolites can penetrate the dermis, potentially triggering the polymerization of ochronotic particles similar to those seen in exogenous ochronosis.
Conclusions
Tyrosinase plays a significant role in hydroquinone-induced exogenous ochronosis, suggesting that hydroquinone acts as a ‘pseudo’ substrate for this enzyme. The findings highlight the importance of using tyrosinase inhibitors to reduce the risk of exogenous ochronosis, while cautioning against other melanogenesis inhibitors that may have similar side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, Japan.
- Research and Development, Beiersdorf AG, Hamburg, Germany.
- Department of Biochemistry, National Institute for Health Sciences, Kawasaki, Japan.
- School of Health Sciences, Gifu University of Medical Science, Seki, Gifu, Japan.
- University Côte d'Azur, CHU Nice, Department of Dermatology, Nice, France.
- Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
ORCID-Profile: Shosuke Ito, Ludger Kolbe, Gudrun Weets, Tamara Rogers, Tomoko Nishimaki-Mogami, Hitomi Tanaka, Thierry Passeron, Makoto Ojika, Kazumasa Wakamatsu
Förderung
- Policy Research
Zitieren
APA
Ito, S., Kolbe, L., Weets, G., Rogers, T., Bushdid, C., Nishimaki-Mogami, T., Tanaka, H., Passeron, T., Ojika, M., & Wakamatsu, K. (2025). Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf273
Vancouver
Ito S, Kolbe L, Weets G, Rogers T, Bushdid C, Nishimaki-Mogami T, et al. Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljaf273
BibTeX
@article{Ito2025,
author = {Ito, Shosuke and Kolbe, Ludger and Weets, Gudrun and Rogers, Tamara and Bushdid, Caroline and Nishimaki-Mogami, Tomoko and Tanaka, Hitomi and Passeron, Thierry and Ojika, Makoto and Wakamatsu, Kazumasa},
title = {Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone},
journal = {British Journal of Dermatology},
year = {2025},
doi = {10.1093/bjd/ljaf273}
}
EUVIMED